Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

Abstract

The suPAR level is higher in patients with type 1 diabetes and is associated with diabetes duration and complications independent of other risk factors. suPAR is a potential novel risk marker for the management of diabetes.